The human amniotic fluid mesenchymal stem cells therapy on SKOV3, ovarian cancer cell line

The human amniotic fluid mesenchymal stem cells therapy on SKOV3, ovarian cancer cell line


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: زهرا فردی آذر , مریم پاشایی اصل

کلمات کلیدی: anticancer therapy, apoptotic genes, cell cycle genes, co‐culture, human amniotic fluid mesenchymal stem cells (hAFMSCs), SKOV3

نشریه: 55881 , 7 , 7 , 2019

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله مریم پاشایی اصل
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه سلامت باروری زنان
کد مقاله 68772
عنوان فارسی مقاله The human amniotic fluid mesenchymal stem cells therapy on SKOV3, ovarian cancer cell line
عنوان لاتین مقاله The human amniotic fluid mesenchymal stem cells therapy on SKOV3, ovarian cancer cell line
ناشر 3
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Abstract Purpose: One of the most common malignancies peculiar to female health with few symptoms, low response to therapy, difficult diagnosis, frequent relapse, and high mortality, is ovarian cancer. Thus, our experiment, using Human amniotic fluid mes‑ enchymal stem cells (hAFMSCs) as a therapeutic tool, aims to find an efficient treat‑ ment approach for patients suffering from SKOV3 ovarian cancer. Material & Methods: In this study, we obtained 5 ml amniotic fluid from 16–20 week pregnant women who underwent amniocentesis for routine prenatal diagnosis by karyotyping in Al‐Zahra Hospital of Tabriz University of Medical Sciences, Iran. Using trans wells in 24 wells plate, hAFMSCs were isolated from all samples, co‐cultured with SKOV3 ovarian cancer cell line, and characterized via flow cytometry and RT‐PCR. Human skin fibroblast cells (HSFCs) were iso‑ lated and used as a negative control. SKOV3 and HSFCs' viability after 5 days was evaluated by MTT assay. Cell cycle and apoptotic genes were analyzed by real‐time PCR. Results: We successfully isolated and characterized hAFMSCs through it positiv‑ ity for CD44 and CD90 specific mesenchymal stem cell markers and negativity for CD31 and CD45. Oct4 and NANOG were evaluated by RT‐PCR as pluripotency markers, and visualized on 2% gel electrophoresis. We established hAFMS cell lines after 5 days of co‐culturing the SKOV3 cells, viability was decreased; however, HSFCs did not show toxicity by MTT assay. The genes indicated upregulation and high expression by a real‐time PCR. Conclusions: Our findings showed that hAFMSCs have natural tumor tropism, and can release soluble factors in a cell culture, which cause an efficient anticancer effect. Thus, we can use hAFMSCs for complete anticancer therapy on SKOV3 cell line at cell culture condition and possibly in vivo in the near future.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
زهرا فردی آذردوم
مریم پاشایی اصلسوم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Gholizadeh......pdf1398/06/14761584دانلود
a-9311.doc1398/08/201288704دانلود